Nephropathy

There are 59 papers on nephropathy in aging research: 6 trials and 19 observational studies in people, 16 in animals, 18 reviews. The newest story, Nov 3, 2026: “Obesity surgery linked to lower risks of complications and death”.

Disease

59 papers study it524 more mention it14 findings

41 new papers in 30 daysSee all 583 papers on nephropathy

“Compared with OMMs, MBS was associated with lower 5-year cumulative incidences of nephropathy”
Cardiovascular and diabetes outcomes after metabolic bariatric surgery versus obesity management medications: nationwide overlap-weighted cohort study of 379 858 patientsThe British journal of surgery2026doi:10.1093/bjs/znag139
  • Human trial6
  • Humans19
  • Animals16

Interventions

3

SGLT2 inhibitors or GLP-1 receptor agonists

no changein humans1RR 1.07

1 study
  1. SGLT2 inhibitors or GLP-1 receptor agonists were not clearly linked with nephropathy in humans (patients without baseline proteinuria, compared with DPP4i) (RR 1.07 (95% CI 0.86-1.32)).

    Humanspatients without baseline proteinuria, compared with DPP4i5 years

More on SGLT2 inhibitors or GLP-1 receptor agonists

Metformin

upin mice1

1 study
  1. Metformin increases nephropathy in mice (as monotherapy).

    Animalsas monotherapymales

More on Metformin

Diet

downin rats1

1 study
  1. Diet decreases nephropathy in ad libitum fed male F344 rats.

    Reviewin ad libitum fed male F344 ratsmales

More on Diet

Associations

11

Metabolic bariatric surgery

downin humans1HR 0.55

1 study
  1. Metabolic bariatric surgery is associated with nephropathy in humans (Obesity and type 2 diabetes; compared with obesity management medications) (4.5% versus 8.3%; -3.8 percentage points; HR 0.55 (95% CI 0.52–0.60)).

    HumansObesity and type 2 diabetes; compared with obesity management medications5 yearsn = 379,858

    Obesity surgery linked to lower risks of complications and death

    The British journal of surgery

More on Metabolic bariatric surgery

Vascular age gap

upin humans1OR 1.22

1 study
  1. Vascular age gap is linked with a higher risk of nephropathy in humans (OR 1.22 per 10-year increase in VAG).

    Humanslogistic models adjusted for age, diabetes duration, blood pressure, body mass index, HbA1c, lipids and smoking

More on Vascular age gap

Age at natural menopause

downin humans1

1 study
  1. Nephropathy is associated with age at natural menopause in humans (Syrian women with type 2 diabetes and nephropathy compared with diabetes-free women).

    HumansSyrian women with type 2 diabetes and nephropathy compared with diabetes-free womenfemales

High Glycemia cluster

upin humans1

1 study
  1. High Glycemia cluster is linked with a higher risk of nephropathy in humans among Central Europeans only; not elevated in South Asians.

    Humansamong Central Europeans only; not elevated in South Asians

Age-related cluster

upin humans1

1 study
  1. Age-related cluster is linked with a higher risk of nephropathy in humans among Central Europeans only; not elevated in South Asians.

    Humansamong Central Europeans only; not elevated in South Asians

SGLT2 inhibitors or GLP-1 receptor agonists

downin humans1RR 0.57

1 study
  1. SGLT2 inhibitors or GLP-1 receptor agonists are linked with a lower risk of nephropathy in humans (patients with baseline proteinuria (ACR ≥ 30 mg/g), compared with DPP4i) (RR 0.57 (95% CI 0.40-0.79)).

    Humanspatients with baseline proteinuria (ACR ≥ 30 mg/g), compared with DPP4i5 years

More on SGLT2 inhibitors or GLP-1 receptor agonists

Cellular senescence

upin humans1

1 study
  1. Cellular senescence predicts nephropathy in humans.

    Humans4 years

More on Cellular senescence

Skin autofluorescence

upin humans1

1 study
  1. Skin autofluorescence predicts nephropathy in humans (AUC 0.56 (95% CI 0.47-0.65)).

    Humansskin

More on Skin autofluorescence

Mortality

upin humans1HR 2.7

1 study
  1. Nephropathy is associated with mortality in humans (peripheral arterial disease; intensified center-based care group) (HR 2.7).

    Humansperipheral arterial disease; intensified center-based care group5 yearsn = 370

Age under 39 years

upin humans1

1 study
  1. Age under 39 years are associated with nephropathy in humans (patients with hypertension).

    Humanspatients with hypertension

All 11

Trial sponsors

Funding

18 grants since 2017

National Institute of Diabetes and Digestive and Kidney Diseases$5.7MJapan Society for the Promotion of Science¥33.2MNational Institute of Environmental Health Sciences$2.9M

Latest

Dec 2025: 12Jan 2026: 23Feb 2026: 30Mar 2026: 25Apr 2026: 9May 2026: 10Jun 2026: 14Jul 2026: 8Aug 2026: 13Sep 2026: 5Oct 2026: 28Nov 2026: 13190 papers in 12 months
The British Journal of Surgery

Obesity surgery linked to lower risks of complications and death

Five-year rates of major heart and blood vessel events were 6.1% after surgery versus 8.1% after starting medication in adults with obesity and type 2 diabetes.Five-year rates of major heart and blood vessel events were 6.1% after surgery versus 8.1% after starting medication in adults with obesity and type 2 diabetes.

Cohort · 379,858 peopleObesity

See all 583 papers on nephropathy